MARKET WIRE NEWS

Waystar Introduces Industry's First AI Solution Addressing Widespread "Silent Denials" from Payer Payment Take-Backs

MWN-AI** Summary

Waystar, a leading healthcare payment software provider, recently launched the industry's first AI-powered solution aimed at tackling the growing issue of "silent denials" stemming from payer payment take-backs, or recoupments. Annually, more than $40 billion in provider revenue is estimated to be reversed through these adjustments, which have surged at a rate more than double that of overall claim volume. The new Waystar AltitudeAI™ solution empowers healthcare providers to recover lost revenue by offering unprecedented visibility into these hidden financial discrepancies.

Waystar's AI-driven platform leverages a proprietary dataset that covers over 7.5 billion healthcare transactions. It dramatically reduces the time required for reconciliation—by more than 80% in early adopters—allowing for faster identification of unjustified recoupments. One early adopter, a health system with an annual revenue of $4 billion, discovered $32 million in previously unrecognized take-backs, which would have required arduous manual work equivalent to 27,000 hours each year.

Payer recoupments, often executed with minimal explanation, have created significant challenges for healthcare providers, leading to substantial financial write-offs and unpredictable cash flows. Many organizations lack the resources to appeal these adjustments due to their opaque nature. Waystar’s innovative approach not only identifies these silent denials but also connects them back to original claims, providing clarity and a pathway for recovery.

In the words of Waystar's CEO, Matt Hawkins, this solution turns previously invisible revenue losses into recoverable assets. With approximately 30,000 clients—including a substantial portion of renowned hospitals—Waystar aims to transform the healthcare revenue cycle, making it easier for providers to focus on patient care while maximizing financial performance. The company will showcase this cutting-edge solution at its upcoming Spring 2026 Innovation Showcase.

MWN-AI** Analysis

Waystar's recent launch of its AI-driven solution targeting "silent denials" could significantly reshape the healthcare payment landscape. The company's AltitudeAI™ technology aims to recover an estimated $40 billion in provider revenues that are silently recouped by payers through post-payment adjustments. With the healthcare industry seeing payer recoupments escalate at more than double the rate of overall claims, this innovation addresses a critical pain point related to revenue loss, cash flow unpredictability, and excessive administrative burdens.

Investors should view Waystar's advancements with optimism. By simplifying the reconciliation process—reducing it by over 80% in initial rollouts—the solution not only enhances financial recovery for healthcare providers but also strengthens their operational efficiency. As operators in the healthcare ecosystem confront growing complexities from payer adjustments, Waystar’s ability to provide transparency and actionable insights positions it well for sustained growth. The hefty $32 million in recoupments surfaced for a single early adopter exemplifies the potential revenue recovery for providers that leverage this technology.

Moreover, with Waystar’s established client base, including major health systems, the adoption trajectory appears promising. The firm’s data-driven approach, which capitalizes on a vast volume of healthcare transactions, sets it apart from competitors. As more providers recognize the financial implications of silent denials, Waystar could see heightened demand for its AI solutions, bolstering its user base and strengthening market position.

For potential investors, now may be an opportune moment to consider Waystar shares. The introduction of innovative products geared toward tangible revenue recovery not only increases the company's value proposition but also signals a forward-thinking strategy in a rapidly evolving healthcare landscape. However, it is essential to remain cognizant of potential risks, including client adoption rates and competitive market pressures as Waystar navigates its growth trajectory.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: PR Newswire

PR Newswire

Targets more than $40 billion in provider payments reversed annually across the industry — growing at more than double the rate of overall claim volume

Waystar AltitudeAI™ advances the autonomous revenue cycle and enables providers to recover significant lost revenue from recoupments at scale

LEHI, Utah and LOUISVILLE, Ky., April 7, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the industry's first AI-powered solution designed to uncover more than $40 billion in estimated provider revenue silently taken back each year through post-payment adjustments known as recoupments.1

The new capability delivers comprehensive visibility and autonomous intelligence into a category of revenue loss that has remained largely undetected and unrecovered — powered by Waystar AltitudeAI™ and informed by the company's proprietary dataset spanning more than 7.5 billion healthcare payment transactions and over $2.4 trillion in annual gross claims.

Advancing Waystar's vision for the autonomous revenue cycle, the solution has reduced reconciliation time by more than 80% in early adopter deployments and, for the first time, provides thorough visibility into payer recoupments, equipping providers to quickly identify unjustified take-backs and pursue appeals they previously had to write off. For an early adopter health system with approximately $4 billion in annual revenue, the solution surfaced $32 million in previously hidden recoupments for review, work that would otherwise require the equivalent of approximately 27,000 hours of manual reconciliation across thousands of transactions annually or 13 full-time employees.

Payer recoupments function as "silent denials" that are increasingly pervasive, opaque, and difficult to manage:

  • Payers routinely recoup funds from previously paid healthcare claims by offsetting them against payments — sometimes months or even years later — with little or no explanation.
  • Recoupments are accelerating, growing at twice the rate of overall claim volume over the last three years, according to Waystar data.
  • Providers often cannot determine which claims were affected, why funds were recouped, or how to respond. As a result, organizations absorb substantial write-offs, experience unpredictable cash flow, and manage significant administrative burden with no clear path to recovery.

"Providers have been losing billions to recoupments they couldn't see, couldn't trace, and couldn't recover — until now," said Matt Hawkins, Waystar Chief Executive Officer. "Waystar sits at the center of billions of healthcare transactions, uniquely enabling us to detect these silent denials and match them to originating claims at a scale no single organization can achieve alone. This is the power of AI applied to one of the most overlooked areas of the revenue cycle — turning invisible revenue loss into recoverable dollars."

Waystar operates at the center of the healthcare payments ecosystem as the connective tissue for the payer–provider–patient network, with the visibility and scale to detect recoupment patterns. The company's unique proprietary data informs new AI capabilities that identify recoupment activity across payers, providers, and care settings; match those adjustments to originating claims with precision; and surface systemic drivers of revenue leakage.

Waystar developed this innovation in partnership with a dozen clients, from the largest health systems to nationwide ambulatory providers, that identified recoupments as one of their most urgent and underserved challenges. Providers often do not appeal or recover — in some cases not because the adjustments are valid, but because the administrative effort required to investigate each one is too high.

"Recoupments were a black box for our team — every single one required manual investigation through remittance data, taking hours to research," said Munday Letournea, who leads billing operations and cash posting for Novocure, an international oncology company with more than 1,300 employees. "Waystar's Recoupment Manager cut that to minutes and gave us something we've never had: a clear view of what's being taken back and why. That changes how we prioritize, how we appeal, and ultimately how much revenue we recover."

Waystar will feature its new recoupments solution and other high-impact innovations at Waystar's Spring 2026 Innovation Showcase: Unveiling the Autonomous Healthcare Revenue Cycle on April 23 at 1 p.m. ET. The online event will demonstrate how embedded agentic intelligence is powering the autonomous revenue cycle within Waystar's platform — from surfacing invisible denial pressure before it compounds to adapting patient financial experiences in real time. Register at waystar.com/innovation-showcase.

Forward-Looking Statements
This press release contains forward?looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected capabilities, benefits, and performance of Waystar's Recoupment Manager solution and Waystar AltitudeAI; the size and growth of the recoupment industry challenge; expected improvements in reconciliation time, visibility, and revenue recovery; and Waystar's vision for the autonomous revenue cycle. Forward?looking statements may be identified by words such as "anticipate," "believe," "expect," "may," "plan," "will," "designed to," and the negative version of these words, or similar terms and phrases that are intended to identify forward-looking statements. These statements are based on current expectations and are subject to risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These risks include, but are not limited to, variability in client adoption and results; uncertainty in market size estimates derived from internal analysis and third?party data; variability in AI?driven claims matching accuracy across payers; changes in payer recoupment and appeals processes; competitive pressures; and other risks described in Waystar's Annual Report on Form 10?K for the year ended December 31, 2025 and subsequent SEC filings. Actual results may differ materially. Except as required by law, Waystar undertakes no obligation to update forward?looking statements.

About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves over 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 7.5 billion healthcare payment transactions, including over $2.4 trillion in annual gross claims and spanning approximately 60% of U.S. patients and one in three U.S. hospital discharges. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

1Based on a recent analysis of Waystar proprietary and industry data.

Media Contact
Kristin Lee
kristin.lee@waystar.com

Investor Contact
investors@waystar.com

SOURCE Waystar

FAQ**

How does Waystar Holding Corp. WAY's new AI solution specifically identify and categorize the "silent denials" resulting from payer payment take-backs, and what metrics are being used to measure its effectiveness in revenue recovery?

Waystar's AI solution identifies "silent denials" by analyzing payment patterns and categorizing discrepancies through machine learning algorithms, measuring effectiveness in revenue recovery using metrics such as recovery rates, denial resolution time, and financial impact on overall revenue.

Given the $40 billion in estimated provider revenue lost to recoupments annually, how does Waystar Holding Corp. WAY plan to scale the adoption of its AltitudeAI™ technology across different healthcare providers and systems?

Waystar Holding Corp. plans to scale the adoption of its AltitudeAI™ technology by leveraging targeted partnerships, demonstrating cost-saving benefits through data-driven insights, and offering tailored solutions that address the unique revenue cycle challenges faced by diverse healthcare providers and systems.

What potential challenges or resistance does Waystar Holding Corp. WAY anticipate from healthcare providers regarding the implementation of this AI-powered Recoupment Manager, especially in integrating it with existing systems?

Waystar Holding Corp. may face challenges from healthcare providers regarding resistance to change, concerns over data security, the need for staff retraining, integration complexities with legacy systems, and potential disruptions to existing workflows during the rollout of the AI-powered Recoupment Manager.

With the solution reportedly reducing reconciliation time by over 80%, what feedback has Waystar Holding Corp. WAY received from early adopters in terms of financial impact and changes in operational efficiency?

Early adopters of Waystar Holding Corp.'s solution have reported significant improvements in financial impact and operational efficiency, highlighting an over 80% reduction in reconciliation time, leading to faster processes and better resource allocation.

**MWN-AI FAQ is based on asking OpenAI questions about Waystar Holding Corp. (NASDAQ: WAY).

Waystar Holding Corp.

NASDAQ: WAY

WAY Trading

5.1% G/L:

$25.36 Last:

92,850 Volume:

$24.98 Open:

SMX Ad 300

WAY Latest News

WAY Stock Data

$4,495,939,701
146,739,819
0.73%
96
N/A
Healthcare Providers & Services
Healthcare
US
LEHI

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App